Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-134684

Chief Operating Officer sold 10,000 shares at an average $28.19 ($281,857)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gault Cheryl · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Sale : show line 1 in the form 10b5-1 −7,161 $28.04 $200,795 162,753 D
2026-03-30 Sale : show line 2 in the form 10b5-1 −2,839 $28.55 $81,062 159,914 D
Open-market sales · 10,000 sh · avg $28.19 · $281,857
Loading xslF345X06/ownership.xml…